Cost-Effectiveness Analysis of the Treatment of Mild and Moderate Alzheimer’s Disease in Brazil

Revista Brasileira de Psiquiatria - Brazil
doi 10.1590/1516-4446-2017-0021
Full Text
Abstract

Available in full text

Date
Authors
Publisher

FapUNIFESP (SciELO)

Related search

Effect of TTP488 in Patients With Mild to Moderate Alzheimer’s Disease

BMC Neurology
MedicineNeurology
2014English

Bapineuzumab for Mild to Moderate Alzheimer’s Disease: A Meta-Analysis of Randomized Controlled Trials

BMC Neurology
MedicineNeurology
2017English

Cost-Effectiveness Analysis of Memantine for Moderate-To-Severe Alzheimer's Disease in the Netherlands

Neuropsychiatric Disease and Treatment
PsychiatryMental HealthBiological Psychiatry
2011English

Prs41 - Cost-Effectiveness of Pirfenidone for the Treatment of Patients With Mild to Moderate Idiopathic Pulmonary Fibrosis in Greece

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Cost-Effectiveness of Treatments for Mild-To-Moderate Obstructive Sleep Apnea in France

International Journal of Technology Assessment in Health Care
Health Policy
2016English

Prs42 - Cost-Effectiveness of Indacaterol/Glycopyrronium in the Treatment of Chronic Obstructive Pulmonary Disease in Brazil

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Cost-Effectiveness Analysis of Routine Rotavirus Vaccination in Brazil

Revista Panamericana de Salud Publica/Pan American Journal of Public Health
EnvironmentalPublic HealthOccupational Health
2008English

Elevations in Serum Dickkopf-1 and Disease Progression in Community-Dwelling Older Adults With Mild Cognitive Impairment and Mild-To-Moderate Alzheimer’s Disease

Frontiers in Aging Neuroscience
AgingCognitive Neuroscience
2019English

Cost-Effectiveness Analysis of Baricitinib Versus Adalimumab for the Treatment of Moderate-To-Severe Rheumatoid Arthritis in Spain

ClinicoEconomics and Outcomes Research
Health PolicyEconomicsEconometricsFinance
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy